These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23287484)

  • 1. [Perceptions of benign prostatic hyperplasia according to the perspective of patients and general practitioners - the Trophée study].
    Lacoin F; Fourcade RO; Rouprêt M; Slama A; Le Fur C; Michel E; Sitbon A; Cotté FE
    Prog Urol; 2013 Jan; 23(1):50-7. PubMed ID: 23287484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic and therapeutic management of the benign prostatic hyperplasia by the general practitioners in the Maine-et-Loire].
    Bigot P; Vannier F; Orsat M; Lebdai S; Huez JF; Fanello S; Azzouzi AR
    Prog Urol; 2010 Jan; 20(1):65-70. PubMed ID: 20123530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.
    Lukacs B; Leplège A; Thibault P; Jardin A
    Urology; 1996 Nov; 48(5):731-40. PubMed ID: 8911517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective follow-up of 3,228 patients suffering from clinical benign prostatic hyperplasia (BPH) treated for 3 years wi alfuzosin in general practice. BPH Group in General Practice].
    Lukacs B; Grange JC; Comet D; Mc Carthy C
    Prog Urol; 1999 Apr; 9(2):271-80. PubMed ID: 10370951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening of clinical benign prostatic hypertrophy in general practice: survey of 18,540 men].
    Flam T; Montauban V
    Prog Urol; 2003 Jun; 13(3):416-24. PubMed ID: 12940193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
    Seftel A; Rosen R; Kuritzky L
    Int J Impot Res; 2007; 19(4):386-92. PubMed ID: 17377613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.
    Ertel P; Adalig B; Demircan I; Lartey B; Manyak MJ
    Int J Clin Pract; 2016 Oct; 70(10):870-880. PubMed ID: 27774780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do general practitioners overestimate the health of their patients with lower education?
    Kelly-Irving M; Delpierre C; Schieber AC; Lepage B; Rolland C; Afrité A; Pascal J; Cases C; Lombrail P; Lang T
    Soc Sci Med; 2011 Nov; 73(9):1416-21. PubMed ID: 21924535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
    Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the attention General Practitioners pay to their patients' mental health problems add to their workload? A cross sectional national survey.
    Zantinge EM; Verhaak PF; de Bakker DH; van der Meer K; Bensing JM
    BMC Fam Pract; 2006 Dec; 7():71. PubMed ID: 17147799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progression.
    Trachtenberg J
    BJU Int; 2005 Jun; 95 Suppl 4():6-11. PubMed ID: 15871730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of symptomatic BPH in France: who is treated and how?
    Lukacs B
    Eur Urol; 1999; 36 Suppl 3():14-20. PubMed ID: 10559626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey conducted on patients' and urologists' perceptions of benign prostatic hyperplasia.
    Kim SI; Kang JY; Lee HW; Seong do H; Cho JS
    Urol Int; 2011; 86(3):278-83. PubMed ID: 21273763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
    Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
    BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are men on 5α-reductase inhibitors appropriately referred to urology? A survey of primary care physicians.
    Yafi FA; Aprikian AG; Tanguay S; Kassouf W
    BJU Int; 2011 Oct; 108(8):1269-73. PubMed ID: 21199285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benign prostatic hyperplasia (BPH): prevalence in general practice and practical approach of French general practitioners. Results of a study based on 17,953 patients].
    Costa P; Ben Naoum K; Boukaram M; Wagner L; Louis JF
    Prog Urol; 2004 Feb; 14(1):33-9. PubMed ID: 15098749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of at-risk patients: dynamic variables.
    Emberton M
    BJU Int; 2006 Apr; 97 Suppl 2():12-5; discussion 21-2. PubMed ID: 16507047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamsulosin: effect on quality of life in 2740 patients with lower urinary tract symptoms managed in real-life practice in Spain.
    Batista JE; Palacio A; Torrubia R; Hernández C; Vicente J; Resel L;
    Arch Esp Urol; 2002; 55(1):97-105. PubMed ID: 11957763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.